股票行情快报：蓝帆医疗（002382）12月4日主力资金净卖出603.74万元

Core Viewpoint - Bluefan Medical (002382) has experienced a decline in stock price and financial performance, indicating potential challenges in the medical device industry [1][3]. Group 1: Stock Performance - As of December 4, 2025, Bluefan Medical's stock closed at 5.46 yuan, down 2.5% with a turnover rate of 0.86% and a trading volume of 85,600 hands, amounting to a total transaction value of 47.07 million yuan [1]. - The net outflow of main funds on December 4 was 6.0374 million yuan, accounting for 12.83% of the total transaction value, while retail investors saw a net inflow of 3.9286 million yuan, representing 8.35% of the total [1]. Group 2: Recent Fund Flow - Over the past five days, the stock has shown a consistent trend of net outflows from main funds, with the highest outflow recorded on December 2 at 12.9393 million yuan, which was 32.24% of the total transaction value [2]. - The net inflow from retail investors peaked on December 2 at 8.4658 million yuan, which was 21.09% of the total transaction value for that day [2]. Group 3: Financial Performance - For the first three quarters of 2025, Bluefan Medical reported a main revenue of 4.182 billion yuan, a year-on-year decrease of 10.15%, and a net profit attributable to shareholders of -286 million yuan, down 30.09% [3]. - The company's gross profit margin stands at 13.66%, significantly lower than the industry average of 51.22%, indicating a challenging competitive position [3]. - The company's total market capitalization is 5.499 billion yuan, with a net asset value of 9.707 billion yuan, ranking 63rd in the industry [3].